V
Vijay Keshav Gore
Researcher at Amgen
Publications - 23
Citations - 1498
Vijay Keshav Gore is an academic researcher from Amgen. The author has contributed to research in topics: Hyperalgesia & Arthritis. The author has an hindex of 13, co-authored 23 publications receiving 1422 citations.
Papers
More filters
Journal ArticleDOI
"Multi-component reactions : emerging chemistry in drug discovery" 'from xylocain to crixivan'.
TL;DR: This review details developments of new, highly atom-economic MCR derived chemical methods, which enable the fast and efficient production of chemical libraries comprised of a variety of biologically relevant templates, and focuses on applications of isocyanide based MCR (IMCR) reactions.
Journal ArticleDOI
Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles
Vassil I. Ognyanov,Chenera Balan,Anthony W. Bannon,Yunxin Bo,Celia Dominguez,Christopher H. Fotsch,Vijay Keshav Gore,Lana Klionsky,Vu Van Ma,Yi-Xin Qian,Rami Tamir,Xianghong Wang,Ning Xi,Shimin Xu,Dawn Zhu,Narender R. Gavva,James J. S. Treanor,Mark H. Norman +17 more
TL;DR: The synthesis and the structure-activity relationships of a series of 2-(4-pyridin-2-ylpiperazin-1-yl)-1H-benzo[d]imidazoles as novel TRPV1 antagonists are described and compound 46ad was among the most potent analogues in this series.
Journal ArticleDOI
Novel Vanilloid Receptor-1 Antagonists: 3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties
Hui-Ling Wang,Jodie Katon,Chenera Balan,Anthony W. Bannon,Charles Bernard,Elizabeth M. Doherty,Celia Dominguez,Narender R. Gavva,Vijay Keshav Gore,Vu Van Ma,Nobuko Nishimura,Sekhar Surapaneni,Phi Tang,Rami Tamir,Oliver R. Thiel,James J. S. Treanor,Mark H. Norman +16 more
TL;DR: Based on its improved overall profile, compound 16p (AMG 628) was selected as a second-generation candidate for further evaluation in human clinical trials as a potential new treatment for chronic pain.
Journal ArticleDOI
MCC/SNAr methodology. Part 2: Novel three-step solution phase access to libraries of benzodiazepines
TL;DR: In this paper, a further application of N -BOC-α-aminoaldehydes in the Ugi condensation reaction, followed by a secondary S N Ar cyclization, accessing arrays of biologically relevant benzodiazepines in good yield and overall purity.
Journal ArticleDOI
Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists.
Nuria A. Tamayo,Yunxin Bo,Vijay Keshav Gore,Vu Van Ma,Nobuko Nishimura,Phi Tang,Hong Deng,Lana Klionsky,Sonya G. Lehto,Weiya Wang,Brad Youngblood,Jiyun Chen,Tiffany L. Correll,Michael D. Bartberger,Narender R. Gavva,Mark H. Norman +15 more
TL;DR: Exploration of the structure-activity relationships of 4 led to the identification of a potent and orally bioavailable TRPM8 antagonist, tetrahydroisoquinoline 87, which demonstrated target coverage in vivo after oral administration in a rat pharmacodynamic model measuring the prevention of icilin-induced wet-dog shakes (WDS).